US Stock MarketDetailed Quotes

Rhythm Pharmaceuticals (RYTM)

Watchlist
  • 108.360
  • +2.410+2.27%
Close Jan 22 16:00 ET
  • 108.360
  • 0.0000.00%
Post 20:01 ET
7.23BMarket Cap-34.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rhythm Pharmaceuticals (RYTM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
54.28%51.3M
66.80%48.5M
25.94%32.7M
68.06%130.13M
72.61%41.83M
47.76%33.25M
51.28%29.08M
126.41%25.97M
227.56%77.43M
175.70%24.23M
Operating revenue
54.28%51.3M
66.80%48.5M
25.94%32.7M
68.06%130.13M
72.61%41.83M
47.76%33.25M
51.28%29.08M
126.41%25.97M
227.56%77.43M
175.70%24.23M
Cost of revenue
43.65%5.5M
88.09%5.54M
29.96%3.65M
43.71%13.37M
17.14%3.79M
58.71%3.83M
31.80%2.95M
97.54%2.81M
336.10%9.3M
214.49%3.23M
Gross profit
55.66%45.8M
64.40%42.96M
25.46%29.06M
71.39%116.76M
81.15%38.04M
46.44%29.42M
53.85%26.13M
130.49%23.16M
216.79%68.13M
170.56%21M
Operating expense
34.30%98.45M
32.50%88.26M
-53.35%76.06M
51.40%382.26M
27.35%79.3M
14.46%73.31M
4.75%66.61M
160.55%163.05M
25.83%252.48M
24.87%62.27M
Selling and administrative expenses
48.19%52.43M
26.18%45.95M
13.68%39.09M
22.78%144.3M
17.78%38.13M
16.09%35.38M
21.20%36.42M
39.57%34.38M
27.71%117.53M
23.02%32.37M
Research and development costs
21.34%46.03M
40.12%42.31M
-71.26%36.97M
76.33%237.96M
37.72%41.17M
12.99%37.93M
-9.98%30.19M
239.08%128.67M
24.23%134.95M
26.94%29.89M
Operating profit
-19.98%-52.65M
-11.90%-45.3M
66.40%-47M
-44.02%-265.5M
0.02%-41.26M
0.15%-43.89M
13.14%-40.48M
-166.29%-139.89M
-2.90%-184.36M
1.99%-41.27M
Net non-operating interest income expense
65.15%-414K
-408.89%-2.58M
-3.57%-1.77M
-11,216.98%-5.89M
-164.30%-1.93M
-474.76%-1.19M
-517.07%-506K
-550.92%-1.71M
104.52%53K
-2,536.67%-731K
Non-operating interest income
6.76%4.33M
-20.87%3.24M
19.47%3.64M
5.49%14.71M
-7.96%3.52M
16.96%4.05M
27.20%4.1M
-11.45%3.05M
246.12%13.95M
25.58%3.82M
Non-operating interest expense
-9.54%4.74M
26.37%5.82M
13.75%5.41M
48.31%20.6M
19.71%5.45M
66.47%5.24M
39.36%4.6M
55.34%4.76M
167.10%13.89M
51.11%4.55M
Other net income (expense)
-74.82%274K
-82.87%1.58M
-222.90%-644K
5,762.63%11.14M
-134.88%-195K
784.28%1.09M
54,229.41%9.2M
2,040.74%524K
124.05%190K
233.10%559K
Gain on sale of security
----
----
----
--8.9M
--0
----
--8.9M
----
----
----
Other non- operating income (expenses)
-74.82%274K
421.85%1.58M
-222.90%-644K
1,078.42%2.24M
-134.88%-195K
784.28%1.09M
1,876.47%302K
2,040.74%524K
124.05%190K
233.10%559K
Income before tax
-20.03%-52.79M
-45.66%-46.3M
64.97%-49.42M
-41.36%-260.26M
-4.69%-43.38M
-0.43%-43.99M
31.95%-31.78M
-170.36%-141.07M
-1.65%-184.11M
2.49%-41.44M
Income tax
132.27%111K
-29.65%337K
-73.33%80K
-38.65%346K
-145.92%-90K
-193.48%-344K
479K
300K
564K
196K
Net income
-21.23%-52.9M
-44.55%-46.63M
64.99%-49.5M
-41.11%-260.6M
-3.98%-43.29M
1.18%-43.64M
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
Net income continuous Operations
-21.23%-52.9M
-44.55%-46.63M
64.99%-49.5M
-41.11%-260.6M
-3.98%-43.29M
1.18%-43.64M
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
Minority interest income
Net income attributable to the parent company
-21.23%-52.9M
-44.55%-46.63M
64.99%-49.5M
-41.11%-260.6M
-3.98%-43.29M
1.18%-43.64M
30.92%-32.26M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
Preferred stock dividends
3.46%1.38M
3.61%1.35M
1.32M
3.97M
1.34M
1.33M
1.3M
Other preferred stock dividends
Net income attributable to common stockholders
-20.70%-54.28M
-42.96%-47.98M
64.05%-50.82M
-43.26%-264.57M
-7.20%-44.63M
-1.83%-44.97M
28.14%-33.56M
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
Basic earnings per share
-12.33%-0.82
-36.36%-0.75
65.53%-0.81
-35.63%-4.34
-2.86%-0.72
3.95%-0.73
32.93%-0.55
-155.43%-2.35
7.78%-3.2
6.67%-0.7
Diluted earnings per share
-12.33%-0.82
-36.36%-0.75
65.53%-0.81
-35.63%-4.34
-2.86%-0.72
3.95%-0.73
32.93%-0.55
-155.43%-2.35
7.78%-3.2
6.67%-0.7
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 54.28%51.3M66.80%48.5M25.94%32.7M68.06%130.13M72.61%41.83M47.76%33.25M51.28%29.08M126.41%25.97M227.56%77.43M175.70%24.23M
Operating revenue 54.28%51.3M66.80%48.5M25.94%32.7M68.06%130.13M72.61%41.83M47.76%33.25M51.28%29.08M126.41%25.97M227.56%77.43M175.70%24.23M
Cost of revenue 43.65%5.5M88.09%5.54M29.96%3.65M43.71%13.37M17.14%3.79M58.71%3.83M31.80%2.95M97.54%2.81M336.10%9.3M214.49%3.23M
Gross profit 55.66%45.8M64.40%42.96M25.46%29.06M71.39%116.76M81.15%38.04M46.44%29.42M53.85%26.13M130.49%23.16M216.79%68.13M170.56%21M
Operating expense 34.30%98.45M32.50%88.26M-53.35%76.06M51.40%382.26M27.35%79.3M14.46%73.31M4.75%66.61M160.55%163.05M25.83%252.48M24.87%62.27M
Selling and administrative expenses 48.19%52.43M26.18%45.95M13.68%39.09M22.78%144.3M17.78%38.13M16.09%35.38M21.20%36.42M39.57%34.38M27.71%117.53M23.02%32.37M
Research and development costs 21.34%46.03M40.12%42.31M-71.26%36.97M76.33%237.96M37.72%41.17M12.99%37.93M-9.98%30.19M239.08%128.67M24.23%134.95M26.94%29.89M
Operating profit -19.98%-52.65M-11.90%-45.3M66.40%-47M-44.02%-265.5M0.02%-41.26M0.15%-43.89M13.14%-40.48M-166.29%-139.89M-2.90%-184.36M1.99%-41.27M
Net non-operating interest income expense 65.15%-414K-408.89%-2.58M-3.57%-1.77M-11,216.98%-5.89M-164.30%-1.93M-474.76%-1.19M-517.07%-506K-550.92%-1.71M104.52%53K-2,536.67%-731K
Non-operating interest income 6.76%4.33M-20.87%3.24M19.47%3.64M5.49%14.71M-7.96%3.52M16.96%4.05M27.20%4.1M-11.45%3.05M246.12%13.95M25.58%3.82M
Non-operating interest expense -9.54%4.74M26.37%5.82M13.75%5.41M48.31%20.6M19.71%5.45M66.47%5.24M39.36%4.6M55.34%4.76M167.10%13.89M51.11%4.55M
Other net income (expense) -74.82%274K-82.87%1.58M-222.90%-644K5,762.63%11.14M-134.88%-195K784.28%1.09M54,229.41%9.2M2,040.74%524K124.05%190K233.10%559K
Gain on sale of security --------------8.9M--0------8.9M------------
Other non- operating income (expenses) -74.82%274K421.85%1.58M-222.90%-644K1,078.42%2.24M-134.88%-195K784.28%1.09M1,876.47%302K2,040.74%524K124.05%190K233.10%559K
Income before tax -20.03%-52.79M-45.66%-46.3M64.97%-49.42M-41.36%-260.26M-4.69%-43.38M-0.43%-43.99M31.95%-31.78M-170.36%-141.07M-1.65%-184.11M2.49%-41.44M
Income tax 132.27%111K-29.65%337K-73.33%80K-38.65%346K-145.92%-90K-193.48%-344K479K300K564K196K
Net income -21.23%-52.9M-44.55%-46.63M64.99%-49.5M-41.11%-260.6M-3.98%-43.29M1.18%-43.64M30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M
Net income continuous Operations -21.23%-52.9M-44.55%-46.63M64.99%-49.5M-41.11%-260.6M-3.98%-43.29M1.18%-43.64M30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M
Minority interest income
Net income attributable to the parent company -21.23%-52.9M-44.55%-46.63M64.99%-49.5M-41.11%-260.6M-3.98%-43.29M1.18%-43.64M30.92%-32.26M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M
Preferred stock dividends 3.46%1.38M3.61%1.35M1.32M3.97M1.34M1.33M1.3M
Other preferred stock dividends
Net income attributable to common stockholders -20.70%-54.28M-42.96%-47.98M64.05%-50.82M-43.26%-264.57M-7.20%-44.63M-1.83%-44.97M28.14%-33.56M-170.94%-141.37M-1.97%-184.68M2.02%-41.63M
Basic earnings per share -12.33%-0.82-36.36%-0.7565.53%-0.81-35.63%-4.34-2.86%-0.723.95%-0.7332.93%-0.55-155.43%-2.357.78%-3.26.67%-0.7
Diluted earnings per share -12.33%-0.82-36.36%-0.7565.53%-0.81-35.63%-4.34-2.86%-0.723.95%-0.7332.93%-0.55-155.43%-2.357.78%-3.26.67%-0.7
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -